Synbiotic SE has acquired 50.1 per cent of Daniel Kruse’s cannabis group in what it has described as the most significant merger for the European cannabis sector.
Equinox has announced its intention to trade on the AIM market of the London Stock Exchange.
The proceeds will accelerate its plans to build an international medical cannabis company.
London’s annual cannabis event returned to explore all aspects of Europe’s cannabis industry.
MGC Pharma has received approval for a dose finding study for its proprietary treatment for the effects of COVID-19.
Harbour Access has been appointed as North American investor relations advisor to provide support for the listing.
US cannabis investment company Thought Leaders has acquired UK CBD brand mellow.
CimetrA™ has been proven through clinical trials to help symptoms of severe Covid-19
Yooma Wellness has acquired the Japanese Wellness brand Vertex Co. for US$12,000,000. Vertically integrated global wellness platform, Yooma Wellness, which
Increasing demand for CBD-infused pet food is contributing to market growth.
MGC Pharmaceuticals has received a Free Trade Certificate in Germany for its product ArtemiC which has shown successful results in
The move sees GenCanna continue to expand across global markets
New analysis shows that the CBD market will see massive growth in the coming years as the compound’s use gains popularity for issues such as anxiety and sleep.
Oxford Cannabinoid Technologies has applied to be admitted to the OTC QB Market in the United States. Oxford Cannabinoid Technologies
Tilray says the move will facilitate a path to the US cannabis market.
A new report has projected the European medical cannabis market to reach $4.2bn by 2027, growing at a GACR of
Cannabis drug manufacturers, consumables and advanced instruments are expected to dominate.
The placing is the largest ever capital raise for a cannabis company on the Aquis exchange.
We won’t spam you
